[Clinical evaluation of trivalent influenza virus split vaccine in patients with cardiovascular diseases].
D000914:Antibodies, Viral / Q000032:analysis*; D002318:Cardiovascular Diseases / Q000276:immunology*; D005260:Female; D006801:Humans; D009980:Influenza A virus / Q000276:immunology; D009981:Influenza B virus / Q000276:immunology; D007252:Influenza Vaccines / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D012306:Risk
D000914:Antibodies, Viral; D007252:Influenza Vaccines
Die klinische Prüfung von trivalentem Influenzavirus-Spaltimpfstoff bei Patienten mit Herz-Kreislauf-Erkrankungen.